Suchergebnisse - "Linton, Kim"

PubPharm (121)

1

Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT) : study protocol for a multi-centre, open-label, randomised, phase II platform trial

enthalten in: BMC cancer | 2024

von McIlroy, G. | Lax, S. | Gaskell, C. | +12

2

Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial

enthalten in: BMC cancer | 2024

von McIlroy, G. | Lax, S. | Gaskell, C. | +12

3

Ibrutinib as first-line therapy for mantle cell lymphoma : a multicenter, real-world UK study

enthalten in: Blood advances | 2024

von Tivey, A. | Shotton, R. | Eyre, T. | +65

4

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma : a UK real-world experience

enthalten in: Blood advances | 2024

von Shotton, R. | Broadbent, R. | Alchawaf, A. | +23

5

Diagnosis and management of mantle cell lymphoma : A British Society for Haematology Guideline

enthalten in: British journal of haematology | 2024

von Eyre, T. | Bishton, M. | McCulloch, R. | +9

CommentIn: Br J Haematol. 2024 Jan;204(1):11-13. - PMID 37880826

6

The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma

enthalten in: Blood | 2024

von Di Ciaccio, P. | Polizzotto, M. | Cwynarski, K. | +35

CommentIn: Blood. 2024 Jan 11;143(2):101-102. - PMID 38206643

7

Guideline for the diagnosis and management of marginal zone lymphomas : A British Society of Haematology Guideline

enthalten in: British journal of haematology | 2024

von Walewska, R. | Eyre, T. | Barrington, S. | +10

8

Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma

enthalten in: Leukemia & lymphoma | 2024

von Hess, G. | Dreyling, M. | Oberic, L. | +22

9

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma : final analysis of the MAGNOLIA study

enthalten in: Blood advances | 2023

von Opat, S. | Tedeschi, A. | Hu, B. | +23

10

Pilot study of lung cancer screening for survivors of Hodgkin lymphoma

enthalten in: Haematologica | 2023

von Broadbent, R. | Crosbie, P. | Armitage, C. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]